Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 4/20 | 0.60 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.60 |
| ▸ | ADRB3 | P13945 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.47 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.47 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL109308 | 0.90 | ALDH1A1 (0.61) | ADRB2ADRB1ADRB3ALDH1A1TSHR | |
| SCHEMBL23484189 | 0.89 | ADRB2 (0.56) | ADRB2ADRB1ADRB3ALDH1A1TSHR | |
| SCHEMBL5164152 | 0.83 | TSHR (0.54) | ADRB2ADRB1ADRB3ALDH1A1TSHR | |
| SCHEMBL7539561 | 0.83 | ADRB2 (0.57) | ADRB2ADRB1ADRB3ALDH1A1RAB9A | |
| SCHEMBL10455395 | 0.83 | ALDH1A1 (0.54) | ADRB2ADRB1ADRB3ALDH1A1TSHR | |
| SCHEMBL163931 | 0.83 | ALDH1A1 (0.54) | ADRB2ADRB1ADRB3ALDH1A1TSHR | |
| SCHEMBL5164967 | 0.83 | ALDH1A1 (0.54) | ADRB2ADRB1ADRB3ALDH1A1TSHR | |
| SCHEMBL6057072 | 0.83 | ADRB2 (0.66) | ADRB2ADRB1ADRB3ALDH1A1TSHR | |
| SCHEMBL20644673 | 0.82 | CA12 (0.58) | ADRB2ADRB1ADRB3ALDH1A1TSHR | |
| SCHEMBL39762 | 0.82 | CA12 (0.63) | ADRB2ADRB1ADRB3ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109695038-B | Pickling roll manufacturing process | 浙江协和薄钢科技有限公司 | 2020-10-13 | — | — | CN | claimed |
| US-20230203058-A1 | MACROCYCLIC DIAMINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS | iTeos Belgium SA (BE) | 2023-06-29 | — | — | US | disclosed |
| CN-109695038-B | Pickling roll manufacturing process | 浙江协和薄钢科技有限公司 | 2020-10-13 | — | — | CN | disclosed |
| CN-109695038-A | Manufacturing process is rolled up in pickling | 浙江协和薄钢科技有限公司 | 2019-04-30 | — | — | CN | disclosed |
| US-10005787-B2 | Highly photo-stable bis-triazole fluorophores | NITTO DENKO CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| US-10005787-B2 | Highly photo-stable bis-triazole fluorophores | NITTO DENKO CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| US-10005787-B2 | Highly photo-stable bis-triazole fluorophores | NITTO DENKO CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| US-20180002337-A1 | HIGHLY PHOTO-STABLE BIS-TRIAZOLE FLUOROPHORES | NITTO DENKO CORPORATION (JP) | 2018-01-04 | — | — | US | disclosed |
| US-20180002337-A1 | HIGHLY PHOTO-STABLE BIS-TRIAZOLE FLUOROPHORES | NITTO DENKO CORPORATION (JP) | 2018-01-04 | — | — | US | disclosed |
| US-9856210-B2 | Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis | KYOTO UNIVERSITY (JP) | 2018-01-02 | — | — | US | disclosed |
| WO-2016112220-A1 | HIGHLY PHOTO-STABLE BIS-TRIAZOLE FLUOROPHORES | NITTO DENKO CORPORATION (JP) | 2016-07-14 | — | — | WO | disclosed |
| WO-2016112200-A1 | THERMAL REGULATING WAVELENGTH CONVERSION FILMS INCORPORATING PHASE CHANGE MATERIALS | NITTO DENKO CORPORATION (JP) | 2016-07-14 | — | — | WO | disclosed |
| US-20130225642-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | KYOTO UNIVERSITY (JP) | 2013-08-29 | — | — | US | disclosed |
| EP-2611437-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | Kyoto University (JP) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012029994-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | KYOTO UNIVERSITY (JP) | 2012-03-08 | — | — | WO | disclosed |
| EP-0658573-B1 | Mannich condensation products of polyalkylene hydroxyaromatic esters and fuel compositions containing the same | CHEVRON CHEM CO (US) | 1998-05-13 | — | — | EP | disclosed |
| EP-0658573-A2 | Mannich condensation products of polyalkylene hydroxyaromatic esters and fuel compositions containing the same | CHEVRON CHEMICAL COMPANY (US) | 1995-06-21 | — | — | EP | disclosed |
| US-5399178-A | Antideposit agents | CHEVRON CHEMICAL COMPANY (US) | 1995-03-21 | — | — | US | disclosed |
| US-4274991-A | PLASTICIZERS | BAYER AKTIENGESELLSCHAFT (DE) | 1981-06-23 | — | — | US | disclosed |
| US-4051122-A | Disazo pigments containing tetracarboxylic acid ester groups | CIBA-GEIGY CORPORATION (US) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180002337-A1 | HIGHLY PHOTO-STABLE BIS-TRIAZOLE FLUOROPHORES | CBR3, TPD52L2, TNS4 | ADRB2 3088/4885ADRB1 3751/4885ADRB3 2552/4885 |
| US-20130225642-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | SMN1; SMN2, SOD1, SOD3 | ADRB2 4470/4885ADRB1 4341/4885ADRB3 2789/4885 |
| US-20230203058-A1 | MACROCYCLIC DIAMINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS | ENTPD1, SLC29A1, ENTPD5 | ADRB2 1048/4885ADRB1 766/4885ADRB3 1212/4885 |
| US-10005787-B2 | Highly photo-stable bis-triazole fluorophores | CBR3, TPD52L2, TNS4 | ADRB2 3088/4885ADRB1 3751/4885ADRB3 2552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.